¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nitrate utilization test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • reduction test
    ȯ¿ø½ÃÇè
  • reference test
    ±âÁذ˻ç¹ý
  • reflex righting test
    Á÷¸³¹Ý»ç°Ë»ç
  • renal function test
    ÄáÆÏ±â´É°Ë»ç, ½ÅÀå±â´É°Ë»ç
  • resorption skin test
    Èí¼öÇǺΰ˻ç
  • respiratory function test
    È£Èí±â´É°Ë»ç
  • right-wrong test
    ¿Ç°í±×¸§°Ë»ç
  • righting function test
    ¹Ù·Î¼­±â±â´É°Ë»ç
  • righting reflex test
    Á÷¸³¹Ý»ç°Ë»ç, ¹Ù·Î¼­±â¹Ý»ç°Ë»ç
  • ring test
    °í¸®Ä§Àü°Ë»ç
  • rotation test
    ȸÀü°Ë»ç
  • Sabin-Feldman dye test
    ¼¼À̺óÆçÆ®¸¸»ö¼Ò¸é¿ª°Ë»ç
  • scratch test
    ±ÜÀºÀÚ±¹°Ë»ç
  • screening test
    ¼±º°°Ë»ç
  • screening hearing test
    ¼±º°Ã»·Â°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • hardness test
    °æµµ½ÃÇè(ÌãöôãËúÐ).
  • harmonic acceleration test
    Á¶È­(¼º) °¡¼Ó°Ë»ç
  • head tilt test
    ¸Ó¸®±â¿ïÀÓ°Ë»ç, µÎÀ§°æ»ç°Ë»ç
  • hearing test
    û·Â°Ë»ç
  • hearing test, objective
    °´°üÀû û·Â°Ë»ç, Ÿ°¢Àû û·Â°Ë
  • hearing test, screening
    ¼±º°Ã»·Â°Ë»ç
  • hearing test, speech
    ¾îÀ½Ã»·Â°Ë»ç
  • heat and acetic acid test
    °¡¿Â¾Æ¼¼Æ®»ê½ÃÇè (¹ý)(ʥ计­ß«ãËúÐÛö).
  • heat instability test
    ¿­ ºÒ¾ÈÁ¤¼º ½ÃÇè<°Ë»ç>
  • heat stability test
    ¿­¾ÈÁ¤¼º°Ë»ç
  • heat test
    ¿­½ÃÇè(ËçËàÌ´).
  • heat test
    ¿­½ÃÇè(æðãËúÐ).
  • heel knee test
    Á¾ºÎ ½½ °Ë»ç£¨ñ¢Ý»ã£ËþÞÛ£©£¬Á¾½½ ½ÃÇè(ñ¢ã£ãËúÐ).
  • heel tap test
    Á¾Å¸½ÃÇè(¡­ãËúÐ).
  • heel to knee to shin test
    Á¾½½°æ½ÃÇè<°Ë»ç> (ñ¢ã£ÌëãËúÐ<ËþÞÛ>).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • direct agglutination test
    Á÷Á¢ÀÀÁý½ÃÇè
  • direct antiglobulin test
    Á÷Á¢Çױ۷κҸ°½ÃÇè.
  • direct antiglobulin test
    Á÷Á¢Çױ۷κҸ°°Ë»ç
  • direct antiglobulin test =DAT
    Á÷Á¢ Çױ۷κҸ° °Ë»ç
  • disc sensitivity test
    ¿øÆÇ°¨¼ö¼º°Ë»ç
  • discrimination test =discriminant t.
    °¨º°½ÃÇè, ¾îÀ½ÆÇº°°Ë»ç.
  • discrimination test =discriminant t.
    °¨º°(Êüܬ)½ÃÇè(ãËúÐ), ¾îÀ½ÆÇº°°Ë»ç.
  • disk diffusion test
    µð½ºÅ©È®»ê½ÃÇè
  • disk dilution susceptibility test
    µð½ºÅ©Èñ¼®°¨¼ö¼º½ÃÇè
  • dithionite solubility test
    µðƼ¿À´ÏÆ®¿ëÇØµµ½ÃÇè
  • dolls eye test
    ÀÎÇü¾È½ÃÇè, ÀÎÇü¾È°Ë»ç.
  • dot blot test
    Á¡Àû(ïÇîÙ)½ÃÇè, Á¡Àû¹ý
  • double blind test
    ÀÌÁ߸Ͱ˹ý<½ÃÇè>.
  • double diffusion (test)
    ÀÌÁßÈ®»ê(½ÃÇè)(¡­üªß¤ãËúÐ).
  • drinking test
    À½¼ö½ÃÇè(ëæâ©ãËúÐ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
VDRL test Venereal Disease Research Laboratory (slide) test
VP test Voges-Proskauer test
ADT Accepted Dental Therapeutics; adenosine triphosphate; admission, discharge, transfer; agar-gel diffu...
AGCT antiglobulin consumption test; Army General Classification Test
AITT arginine insulin tolerance test; augmented insulin tolerance test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
HPT Hepaplastin test
H.R.T. Histamine release test
HBDT Human Basophil Degranulation Test
HVPT Hyperventilation Provocation Test
HOST Hypo-osmotic swelling test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • in vitro test
    ½ÃÇè°ü³» ½ÃÇè
  • indirect tensile test
    °£Á¢ ÀÎÀå °­µµ ½ÃÇè
  • indole test
    Àε¹ ½ÃÇè
  • intradermal test
    Çdz» °Ë»ç
    1. È÷½ºÅ¸¹Î, Åõº£¸£Ä𸰠µîÀ» ÁøÇÇ ³»¿¡ ÁÖ»çÇϰí ÀÏÁ¤ ±â°£ ÈÄ ¹ÝÀÀÀ» °üÂûÇÏ´Â °Ë»ç. 2. Ç׿øÀ» Çdz» ÁÖ»çÇÏ´Â ÇǺΠ¹ÝÀÀ °Ë»ç.
  • irresistable impulse test
    ¾ïÁ¦ ºÒ´É¼º Ãæµ¿ ½ÃÇè, ºÒ°¡Ç×·ÂÀû Ãæµ¿ °Ë»ç
  • isometric stress test
    µîô¼º ½ºÆ®·¹½º °Ë»ç
  • isopropanol stability test
    À̼ÒÇÁ·ÎÆÄ³î ¾ÈÁ¤¼º °Ë»ç
  • Jacobsthal's test
    ¾ßÄß½ºÅ» ¸Åµ¶ Ç÷û ¹ÝÀÀ
  • Jaeger test
    ¿¹°Å ½ÃÇè
    °¡º±°Ô ¼Õ»ó½ÃŲ ºÎÀ§¿¡ ½Ã¾àÀ» ¹ß¶ó¼­ ÇǺÎÀÇ ¾Ë·¹¸£±â¸¦ ½ÃÇèÇÏ´Â ¹æ¹ý.
  • Jaeger's test type
    ¿¹°Å ¹®ÀÚ
    ½Ã·Â °Ë»ç¿¡ »ç¿ëµÇ´Â ´ë¼ÒÀÇ ¹®ÀÚ¸¦ ´Ã¾î³õÀº Ç¥.
  • Jaffe's test
    ¾ßÆä ½ÃÇè
    ÀεðÄ­ °ËÃâ¹ý.
  • Kahns test
    Ä­ ¸Åµ¶ Ç÷û °Ë»ç
    ¸Åµ¶ Ç÷ûÀÇ Ä§°­ ¹ÝÀÀÀ¸·Î, ºñµ¿È­µÈ ÇǰËÇ÷û 3cc·Î Èñ¼®ÇÑ Ç׿ø 0.05cc¸¦ °¡ÇØ, ÇÏ·ç ¹ãÀ» 37µµ·Î À¯ÁöÇÏ¿© ħÀüÀÌ ³ªÅ¸³ª¸é ¾ç¼º.
  • Kajdi's test
    Ä«À̵ð ½ÃÇè
    ±«Ç÷º´ Áø´Ü¿¡ ÀÌ¿ëµÇ´Â ½ÃÇèÀ¸·Î, ¾Æ½ºÄÚ¸£ºó»ê 200mgÀ» ±ÙÀ°ÁÖ»çÇϰí, 4½Ã°£ ÈÄ¿¡ Ç÷ÁßÀÇ ¾Æ½ºÄÚ¸£ºó»ê·®ÀÌ 0.2mg% ÀÌÇÏÀ̸é, ºñŸ¹Î C°¡ Æ÷È­¿¡ À̸£Áö ¾Ê¾Ò´Ù°í ÆÇÁ¤ÇÑ´Ù.
  • Kamnitzer's test
    °¨´Öó ½ÃÇè
    ÀӺο¡°Ô Ç÷θ®Áø 2.5mgÀ» Åõ¿©ÇÏ¸é ´ç´¢°¡ ¹ß»ýÇÏ´Â ¹ÝÀÀÀ» ÀÌ¿ëÇÑ ÀӽнÃÇè.
  • Kasanin-Vigotsky's test
    Ä«»ç´Ñ-ºñ°íÃ÷Ű ½ÃÇè
    ´ë³úÀÇ ±âÁú¼º Áúȯ°ú ºÐ¿­¼º »óŸ¦ ±¸º°Çϱâ À§ÇÑ ½ÃÇè.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
cis trans test <molecular biology> The complementation test with two or more interacting genes placed in cis and in trans relationships to each other. A double mutant genome is used in the cis test made from the two single mutant genomes used in the trans test by recombination.
If the wild type phenotype is restored by both cis and trans arrangements it is concluded that the two mutations are in different genes and hence that the phenotype is determined by more than one gene. If the trans test is negative and the cis positive this means that the two mutations are in the same gene. If both tests are negative then at least one of the mutations must be dominant. Thus the double test provides a means of fine mapping of genes.
A lab test which is used to determine whether two mutations of different genes which affect the same phenotype are on the same functional unit (indicating a cis configuration of the mutated genes) or on different functional units (indicating a trans configuration of the mutated genes). (A functional unit can be a chromosome.)
The test is done by mating an individual that has one of the mutations to an individual that has the other one, and observing whether their offspring have the mutant phenotype. If the offspring do not have the mutant phenotype, then the genes are known to be trans, because the offspring have normal copies of each mutant gene on the different functional units which are able to genetically complement each other. If the offspring do have the mutant phenotype, then the genes are known to be cis, because the offspring will always inherit at least one of the mutant genes on the one functional unit, resulting in the mutant phenotype.
(09 Oct 1997)
citric acid urine test <investigation> A test which measures the amount of citric acid in the urine. This test is used to diagnose renal tubular acidosis and evaluate those with kidney stones.
A below normal level of citric acid in the urine can indicate renal tubular acidosis. Urine citric acid levels can be increased in those with have a high carbohydrate diet, are on oestrogen therapy or vitamin D therapy.
(27 Sep 1997)
milk-ring test A special form of agglutination test done on the pooled milk of many cows, usually entire herds, for the detection of herds containing individuals infected with bovine brucellosis.
(05 Mar 2000)
Millon Clinical Multiaxial Inventory test A paper and pencil test, consisting of 20 clinical scales derived from 175 self-descriptive statements, and developed in 1977 for use in the assessment of psychopathology and the more enduring patterns of personality; specifically designed to correspond with some of the disorders of personality included in the Diagnostic and Statistical Manual of Mental Disorders used in diagnosis by mental health professionals.
Synonym: Millon clinical multiaxial inventory.
(05 Mar 2000)
Millon-Nasse test A test for protein, the tyrosine of which reacts with nitrite after a brief treatment with mercuric ion in acid to give a colour.
(05 Mar 2000)
Clauberg test A test for progestational activity; immature rabbits are treated with 8 daily injections of oestrogen and then given 5 daily injections of the test substance; the amount required to produce definite progestational changes in the endometrium is taken as the unit; it is equivalent to 0.75 mg of progesterone.
(05 Mar 2000)
photo-patch test A test of contact photosensitization: after application of a patch with the suspected sensitiser for 48 hours to two sites, if there is no reaction one area is exposed to a weak erythema dose of sunlight or ultraviolet light; if positive, a more severe reaction with vesiculation develops at the exposed patch area than the nonexposed skin patch site.
(05 Mar 2000)
Minnesota multiphasic personality inventory test A questionnaire type of psychological test for ages 16 and over, with 550 true-false statements coded in 4 validity and 10 personality scales which may be administered in both an individual or group format.
Synonym: Minnesota Multiphasic Personality Inventory.
(05 Mar 2000)
photostress test Measurement of visual acuity before and after exposure of the eyes to intense light.
(05 Mar 2000)
phrenic pressure test Pressure is made on the phrenic nerve on each side, above the clavicles where the nerve passes over the scalenus anticus muscle; if pain is felt and the patient inclines his head to the painful side, the problem is in the pleural space; if his head does not incline to one side, the problem is in the abdominal cavity.
(05 Mar 2000)
clomiphene test A test of pituitary gonadotropin reserve using clomiphene.
(05 Mar 2000)
phthalein test An obsolete test for renal function; after the patient has drunk a glass or two of water, 1 ml of a 0.6% solution of dye is injected hypodermically; the time between this injection and the appearance of a pink tinge in the urine as it falls into an alkaline solution is noted; the amount excreted in each of the next 2 hours is then estimated colourimetrically.
Synonym: Geraghty's test, phthalein test, red test, Rowntree and Geraghty test.
(05 Mar 2000)
mixed lymphocyte culture test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
MLC test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
CO2-withdrawal seizure test Utilization of hyperventilation to demonstrate abnormalities in the brain waves or even to precipitate a convulsion.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
ÅëÇÕ°Ë»ö ¿Ï·á